Literature DB >> 17555426

Determinants of the short-term gastric damage caused by NSAIDs in man.

I Bjarnason1, C Scarpignato, K Takeuchi, K D Rainsford.   

Abstract

BACKGROUND: The short-term gastric damage seen with non-steroidal anti-inflammatory drugs (NSAIDs) in man may involve inhibition of cyclooxygenase (COX-1) and COX-2 as well as the topical irritancy, which is dependant on the acidity (pKa) and/or lipophilicity (log P(7.4)). AIM: To study the quantitative relationship between NSAID-induced short-term gastric damage, their physicochemical properties and contrasting roles of COX-1 and COX-2 inhibition.
METHODS: We identified studies that allowed a qualitative comparison of the gastric injury (Lanza scores) induced by NSAIDs with their pKa and log P(7.4). Damage was correlated with gastric COX inhibition and potency to inhibit COX-1 and 2 and their COX-2/COX-1 selectivity ratio.
RESULTS: The gastric damage correlates significantly with pKa (r = -0.69; P < 0.01), log P (r = -0.58, P < 0.05) and potency of the NSAIDs to inhibit COX-1 (r = -0.61, P < 0.02), but not with COX-2 inhibition or COX-2/COX-1 selectivity.
CONCLUSION: Against a background of COX-1 and COX-2 inhibition, the physicochemical properties of NSAID appear to play an important role in short-term gastric damage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17555426     DOI: 10.1111/j.1365-2036.2007.03348.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  15 in total

1.  Serious upper gastrointestinal complications of NSAIDs and COX-2 selective agents.

Authors:  Guy Sisson; Ingvar Bjarnason
Journal:  Inflammopharmacology       Date:  2011-05-01       Impact factor: 4.473

Review 2.  Gastrointestinal effects of aspirin.

Authors:  Carlos Sostres; Angel Lanas
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06-07       Impact factor: 46.802

3.  Gastric acid secretion level modulates the association between Helicobacter pylori infection and low-dose aspirin-induced gastropathy.

Authors:  Katsunori Iijima; Nobuyuki Ara; Yasuhiko Abe; Tomoyuki Koike; Wataru Iwai; Kaname Uno; Naoki Asano; Akira Imatani; Shuichi Ohara; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2011-02-26       Impact factor: 7.527

Review 4.  Intestinal permeability in the pathogenesis of NSAID-induced enteropathy.

Authors:  Ingvar Bjarnason; Ken Takeuchi
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

5.  Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I trial.

Authors:  Patricia A Thompson; Chiu-Hsieh Hsu; Sylvan Green; Alison T Stopeck; Karen Johnson; David S Alberts; H-H Sherry Chow
Journal:  Cancer Prev Res (Phila)       Date:  2010-01

Review 6.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

7.  Antiulcer properties of Glycyrrhiza glabra L. extract on experimental models of gastric ulcer in mice.

Authors:  Ghader Jalilzadeh-Amin; Vahid Najarnezhad; Ehsan Anassori; Mostafa Mostafavi; Hadi Keshipour
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

Review 8.  Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits.

Authors:  Kok Ann Gwee; Vernadine Goh; Graca Lima; Sajita Setia
Journal:  J Pain Res       Date:  2018-02-14       Impact factor: 3.133

Review 9.  Piroxicam-β-cyclodextrin: a GI safer piroxicam.

Authors:  C Scarpignato
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 10.  Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practice.

Authors:  Kok Yuen Ho; Kok Ann Gwee; Yew Kuang Cheng; Kam Hon Yoon; Hwan Tak Hee; Abdul Razakjr Omar
Journal:  J Pain Res       Date:  2018-09-20       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.